C. Taylor

First name
C.
Middle name
J.
Last name
Taylor
Taylor, C. J., Hodgkinson, J., & Hobbs, F. D. (2010). Rhythm control agents and adverse events in patients with atrial fibrillation. Int J Clin Pract. http://doi.org/10.1111/j.1742-1241.2010.02426.x
Hodgkinson, J. A., Taylor, C. J., & Hobbs, F. D. (2011). Predictors of incident atrial fibrillation and influence of medications: a retrospective case-control study. Br J Gen Pract. http://doi.org/10.3399/bjgp11X578034
Hodgkinson, J. A., Taylor, C. J., & Hobbs, F. D. (2012). Treatment pathways for patients with atrial fibrillation. Int J Clin Pract. http://doi.org/10.1111/j.1742-1241.2011.02818.x
Taylor, C. J., Ordonez-Mena, J. M., Roalfe, A. K., Lay-Flurrie, S., Jones, N. R., Marshall, T., & Hobbs, F. D. R. (2019). Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study. Bmj. http://doi.org/10.1136/bmj.l223
Taylor, C. J., Ordonez-Mena, J. M., Jones, N. R., Roalfe, A. K., Lay-Flurrie, S., Marshall, T., & Hobbs, F. D. R. (2020). National trends in heart failure mortality in men and women, United Kingdom, 2000-2017. Eur J Heart Fail. http://doi.org/10.1002/ejhf.1996
Taylor, C. J., Lay-Flurrie, S. L., Ordonez-Mena, J. M., Goyder, C. R., Jones, N. R., Roalfe, A. K., & Hobbs, F. R. (2021). Natriuretic peptide level at heart failure diagnosis and risk of hospitalisation and death in England 2004-2018. Heart. http://doi.org/10.1136/heartjnl-2021-319196
Roalfe, A. K., Lay-Flurrie, S. L., Ordonez-Mena, J. M., Goyder, C. R., Jones, N. R., Hobbs, F. D. R., & Taylor, C. J. (2021). Long term trends in natriuretic peptide testing for heart failure in UK primary care: a cohort study. Eur Heart J. http://doi.org/10.1093/eurheartj/ehab781